BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35501999)

  • 21. [Thrombotic thrombocytopenic purpura].
    Yoshitaka M
    Rinsho Ketsueki; 2021; 62(5):430-434. PubMed ID: 34108326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The frontline of TMA management].
    Saito K; Matsumoto M
    Rinsho Ketsueki; 2022; 63(5):463-470. PubMed ID: 35662172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic-therapeutic algorithm for thrombotic microangiopathy. A report of two cases.
    Rubio-Haro R; Quesada-Carrascosa M; Hernández-Laforet J; Ferrer Gómez C; De Andrés J
    Rev Esp Anestesiol Reanim (Engl Ed); 2022 Mar; 69(3):179-182. PubMed ID: 35283062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical consult: aHUS, TTP? How to distinguish and what to do.
    Story CM; Gerber GF; Chaturvedi S
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):745-753. PubMed ID: 38066937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.
    Scully M; Rayment R; Clark A; Westwood JP; Cranfield T; Gooding R; Bagot CN; Taylor A; Sankar V; Gale D; Dutt T; McIntyre J; Lester W;
    Br J Haematol; 2023 Nov; 203(4):546-563. PubMed ID: 37586700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case off TTP temporally associated with cocaine use: Implications for treatment of suspected DITMA.
    Regner SR; Lerfald N
    J Clin Apher; 2019 Aug; 34(4):510-512. PubMed ID: 30776151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal Thrombotic Microangiopathy: A Review.
    Genest DS; Patriquin CJ; Licht C; John R; Reich HN
    Am J Kidney Dis; 2023 May; 81(5):591-605. PubMed ID: 36509342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre.
    Tufano A; Polimeno M; Matani B; Cardillo G; Capasso F; Mormile R; Paladino F; Di Minno G
    Blood Transfus; 2023 Jul; 21(4):345-349. PubMed ID: 35969133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential impact of a delayed ADAMTS13 result in the treatment of thrombotic microangiopathy: an economic analysis.
    Kim CH; Simmons SC; Wattar SF; Azad A; Pham HP
    Vox Sang; 2020 Jul; 115(5):433-442. PubMed ID: 32227485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory.
    Studt JD; Kremer Hovinga JA; Alberio L; Bianchi V; Lämmle B
    Swiss Med Wkly; 2003 Jun; 133(23-24):325-32. PubMed ID: 12923683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lupus nephritis combined with renal injury due to thrombotic thrombocytopaenic purpura-haemolytic uraemic syndrome.
    Yu F; Tan Y; Zhao MH
    Nephrol Dial Transplant; 2010 Jan; 25(1):145-52. PubMed ID: 19703836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinguishing and overlapping laboratory results of thrombotic microangiopathies in HIV infection: Can scoring systems assist?
    Louw S; Jacobson BF; Mayne ES
    J Clin Apher; 2022 Oct; 37(5):460-467. PubMed ID: 36054148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombotic microangiopathy and indications for therapeutic plasma exchange.
    Adamski J
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):444-9. PubMed ID: 25696892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort.
    Bentley MJ; Wilson AR; Rodgers GM
    Vox Sang; 2013 Nov; 105(4):313-8. PubMed ID: 23662653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Intern Med J; 2018 Jun; 48(6):624-636. PubMed ID: 29582550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic Microangiopathy Syndrome in a Basic Underwater Demolition/SEAL Student.
    Croom D; Tracy H
    J Spec Oper Med; 2016; 16(3):16-19. PubMed ID: 27734437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.